Search Results - "Limouris, G"

Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases by Limouris, G S, Poulantzas, V, Trompoukis, N, Karfis, I, Chondrogiannis, S, Triantafyllou, N, Gennimata, V, Moulopoulou, L.-E, Patsouris, E, Nikou, G, Michalaki, V, Fragulidis, G, Paphiti, M, McCready, R V, Colletti, P M, Cook, G J, Rubello, D

“…AIMIn patients with progressive, metastatic neuroendocrine tumors (NET), intra-arterial radionuclide infusions with high activities of In-[DTPA]-octreotide and…”
Get full text

Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors by Limouris, G S, Karfis, I, Chatzioannou, A, Paphiti, M I, Lyra, M, Gennatas, K, Nikou, G, Voros, D, Pragulidis, G P, Polydorou, A A, Gouliamos, A

“…Aim of this study was to evaluate the effectiveness of non-carrier added (n. c. a.) [177Lu]DOTA-TATE in inoperable liver metastases, positive for sst2 receptor…”
Get full text

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy by Zafeirakis, A, Zissimopoulos, A, Baziotis, N, Limouris, G S

“…In this study, a new method has been used to predict pain response to (186)Re-HEDP therapy in patients suffering from painful osseous metastases, on the basis…”
Get full text

A case of hepatic flexure carcinoid with extended brain metastases by Papaconstantinou, I, Lykoudis, P M, Contis, J C, Limouris, G S, Trafalis, D T

Get more information

Imaging and localization of pancreatic insulinomas by Chatziioannou, A, Kehagias, D, Mourikis, D, Antoniou, A, Limouris, G, Kaponis, A, Kavatzas, N, Tseleni, S, Vlachos, L

“…For pancreatic insulinomas, the treatment of choice is surgical excison, which when successful is curative. Intraoperative palpation combined with…”
Get full text

Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy by Kontogeorgakos, D., Limouris, G. S., Kamenopoulou, V., Carinou, E., Papanikolos, G., Vlahos, L., Dimitriou, P.

“…According to the Euratom Directives (96/29, 97/43), the doses received by the workers as well as the family of patients and third persons during medical…”
Get full text

PP25.03 BIODISTRIBUTION AND RADIATION DOSIMETRY COMPARISON OF THE PSMA AGONISTS (177Lu-PSMA I&T, 99mTc-Hynic PSMA AND 99Tc-PSMA I&T) TO THE 177Lu-RM2 ANTAGONIST by Limouris, G., Krylov, V., Dolgushin, M., Paphiti, M., Manetou, A., Roussopoulos, K., Zafeirakis, A.

Get full text

PP25.14 TANDEM SURGERY AND PRRT WITH 177Lu-DOTA-NOC EFFICACY AFTER INTRA-ARTERIAL IMPLEMENTATION IN LIVER METASTASIZED VIPOMA NETS by Limouris, G., Dolgushin, M., Krylov, V., Paphiti, M., Manetou, A., Roussopoulos, K., Zafeirakis, A.

Get full text

Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases by Limouris, G S, Shukla, S K, Condi-Paphiti, A, Gennatas, C, Kouvaris, I, Vitoratos, N, Manetou, A, Dardoufas, C, Rigas, V, Vlahos, L

“…The efficacy and toxicity of treatment with 1400 +/- 100 MBq of Re-186-HEDP were evaluated in women with osseous metastatic breast cancer. The follow-up period…”
Get more information

Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer by Limouris, G, Shukla, S K, Manetou, A, Kouvaris, I, Plataniotis, G, Triantafyllou, N, Rigas, A V, Vlahos, L

“…Prostate carcinoma is the most commonly associated with osseous metastases malignancy in males. The lesions, being usually of a mixed sclerotic/lytic variety…”
Get more information

Renal cell carcinoma detection and systemic therapy with tumour-affine gallium-67 and with yttrium-90 citrate solutions by Shukla, S K, Limouris, G S, Cusumano, R, Acconcia, A, Cipriani, C, Argiro, G, Atzei, G, Boemi, S

“…There have been no major advances in the systemic detection of renal cell carcinoma (RCC) and its unpredictable metastases. Surgery, thus, remains the mainstay…”
Get more information

Advanced prostate cancer diagnosis and therapy with gallium-67 and yttrium-90, respectively by Shukla, S K, Limouris, G S, Cusumano, R, Acconcia, A, Cipriani, C, Atzei, G, Argirò, G, Boemi, S

“…Androgen deprivation therapy remains so far the mainstay of advanced prostate cancer treatment. Although it improves the quality of life of the patient for…”
Get more information

Gastric uptake during Re-186 HEDP bone scintigraphy by Limouris, G S, Skukla, S K

“…In bone scintigraphy extraosseous uptake of the radiopharmaceutical (TcO4-, pertechnetate) is a common finding when the stomach is abnormally observed; this…”
Get more information

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after 186Re-HEDP therapy by Zafeirakis, A, Zissimopoulos, A, Baziotis, N, Limouris, G S

“…In this study, a new method has been used to predict pain response to 186Re-HEDP therapy in patients suffering from painful osseous metastases, on the basis of…”
Get full text

Effects in the testes after SPECT myocardial perfusion with Tl-201 or Tc-99m hexaMIBI by Manetou, A, Limouris, G S

“…Thallium-201 with a half-life of 73 hours, decays by electron capture and as a consequence emits numerous Auger electrons. When it localises in the cell…”
Get more information

Thalassemic osteoarthropathy treated by radiotherapy by Papavasiliou, C, Plataniotis, G, Limouris, G, Kalovidouris, A, Gouliamos, A, Vlahos, L

Get more information

Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice by Zafeirakis, Athanasios, Zissimopoulos, Athanasios, Baziotis, Nikolaos, Limouris, Georgios S

“…The aim of this study was to compare pain response and hematologic toxicity between single and multiple therapies with (186)Re-HEDP under zoledronic acid in…”
Get more information

Protein meal and gastrin levels: a radioisotopic study in vitro by Limouris, G, Flevaris, C, Constantoulakis, M, Danielides, I C

Get more information

Optimization of doses received by the hospital staff and the members of the family of patients undergoing super(111)In-DTPA-D-Phe super(1)-Octreotide therapy by Kontogeorgakos, D, Limouris, G S, Kamenopoulou, V, Carinou, E, Papanikolos, G, Vlahos, L, Dimitriou, P

“…According to the Euratom Directives (96/29, 97/43), the doses received by the workers as well as the family of patients and third persons during medical…”
Get full text

Patient specific computer automated dosimetry calculations during therapy with 111In octreotide by Vamvakas, I., Logopati, N., Andreou, M., Sotiropoulos, M., Gatzis, A., Limouris, G., Antypas, C., Lyra, M.

“…The aim of this study was to calculate the absorbed dose of 22 patients that were diagnosed for neuroendocrine tumours in liver and had received therapeutic…”
Get full text